FIG 2.

Spectrum of myeloid driver mutations in the BMT CTN 1102 study. A comutation plot shows mutations in individual genes per study arm as labeled on the top. Mutations are depicted by colored bars and each column represents one of the 309 patients. ^aSignificant with P < .05 (Fisher's exact test). ^bSelection of patients with de novo MDS with IPSS intermediate-2 or high risk age 50-75 years from a matched retrospective cohort.³ BMT CTN, Blood and Marrow Transplant Clinical Trials Network; IPSS, International Prognostic Scoring System; MDS, myelodysplastic syndrome.